414.2 ð åèçïŒé«åž«åè / PGY OSCEïŒ
414.2.0.1 ð Cram Sheet
414.2.0.1.1 ð¥ é« yield 10
- Obesity = chronic disease (not lifestyle)
- BMI ⥠30 (Asian ⥠27), WC > 102/88 (US) or > 90/80 (Asian)
- Hunger: ghrelin (stomach), AgRP/NPY (hypothalamic), cortisol
- Satiety: leptin, insulin, GLP-1, GIP, PYY, CCK, MC4R signaling
- Visceral > subcutaneous in pathogenicity
- Adipokine imbalance: â adiponectin, â TNF/IL-6/leptin (resistance)
- MC4R mutation = most common monogenic (5% severe early-onset)
- Prader-Willi: 15q11.2 deletion, hyperphagia, hypogonadism
- Drug-induced: steroid, atypical antipsychotic, insulin
- Setmelanotide for MC4R/POMC/LEPR rare monogenic
414.2.0.2 â é« yield
414.2.0.2.1 Hormones Quick
| Hunger | Satiety |
|---|---|
| Ghrelin | Leptin |
| AgRP/NPY | Insulin |
| Cortisol | GLP-1 |
| CB1 | GIP |
| PYY | |
| CCK | |
| Amylin | |
| α-MSH (POMC â MC4R) |
414.2.0.2.2 Genetic Obesity
| Gene | Feature |
|---|---|
| MC4R | Most common monogenic (5%) |
| POMC | Severe early-onset |
| LEPR | Severe early-onset |
| LEP | Leptin def (very rare) |
| PCSK1 | Rare |
| FTO | Polygenic risk |
414.2.0.2.3 Syndromic Obesity
| Syndrome | Features |
|---|---|
| Prader-Willi (15q11.2) | Hyperphagia, hypogonadism, intellectual |
| Bardet-Biedl | Obesity + retinitis pigmentosa + polydactyly + renal |
| Alström | Obesity + multi-organ + retinal |
| WAGR (11p13) | Obesity + tumor risk + intellectual |
414.2.0.3 ð¯ èªææª¢æž¬
- BMI Asian obese? â ⥠27 (å°ç£ ⥠27.5)
- WC Asian ç· / 女? â > 90 / > 80
- Hunger hormone main? â Ghrelin
- Satiety hormones 5? â Leptin, insulin, GLP-1, PYY, CCK
- MC4R signaling? â α-MSH â MC4R = satiety
- Most common monogenic obesity? â MC4R (~5% severe)
- Setmelanotide for? â MC4R/POMC/LEPR
- Prader-Willi region? â 15q11.2
- Bardet-Biedl features? â Obesity + RP + polydactyly + renal
- Drug-induced top 3? â Steroid, atypical antipsychotic, insulin
- Visceral vs subcutaneous? â Visceral pathogenic
- BAT activation? â Cold exposure, exercise; UCP-1
- Leptin in obesity? â Resistance (high level, not work)
- Adiponectin in obesity? â â (anti-inflammatory loss)
- Microbiome obesity? â Firmicutes:Bacteroidetes ratio â
â ïž AI èçš¿ã